Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

10 Apr 2015 07:00

RNS Number : 7922J
Polar Capital Holdings PLC
10 April 2015
 

10 April 2015

Polar Capital Holdings plc

AUM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group") the specialist asset manager today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

 

Group AUM (unaudited)

Polar Capital reports that as at 31 March 2015 its AUM were $12.3bn compared to $12.9bn at the end of December 2014 and $13.2bn at the end of March 2014.

 

The table below sets out the movements in Polar Capital's AUM over the twelve month period:

AUM movement

twelve months to 31 March 2015

Long only funds

$m

Alternative funds

$m

Total

$m

As at 31 March 2014

$12,315m

$934m

$13,249m

Net subscriptions / (redemptions)

$(2,228)m

$254m

$(1,974)m

Closure of EMN team

Nil

$(67)m

$(67)m

Market movement and performance

$1,098m

$(50)m

$1,048m

Total AUM at 31 March 2015

$11,185m

$1,071m

$12,256m

 

Comment

Net inflows across the Group's non Japan range of funds of $0.3bn over the past twelve months have been offset by $2.3bn of outflows from our Japan business ($1.6bn over the past six months) following both disappointing performance that has been exacerbated by the team's style bias, as well as uncertainty over the direction of the Japanese equity market. These Japan flows follow the $3.0bn of net inflows that were received in the previous twelve month period.

 

The combination of these Japan outflows with good inflows into a number of our other products over the year has delivered the side effect of making the business more balanced with Japan now accounting for some 30% of the Group's AUM down from its peak of 43%.

 

We continue to believe that over the medium term the Group is well placed to grow assets further given the number of products that have considerable scope for asset growth including the launch of 3 new funds over the past year. This assumes there is no meaningful deterioration in the overall outlook for global equity markets.

 

The confidence in our ability to grow assets in the medium term is a function of the strong performance of our products that can be demonstrated by the good performance numbers of Polar Capital's product range where 11 of our 14 Lipper rated open ended funds (with at least a 1 year track record) are over one year first or second quartile continuing the excellent record since inception.

 

 

1 year

3 Years

5 years

Since

inception

1st quartile

6 funds

5 funds

5 funds

10 funds

2nd quartile

5 funds

3 funds

N/A

3 funds

3rd quartile

1 fund

1 fund

1 fund

1 fund

4th quartile

2 funds

1 fund

N/A

N/A

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)

John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Broker

Simon Bridges (QE)

Martin Green

Sunil Duggal

Kit Stephenson

+44 (0)20 7523 8000

 

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASLNESPSEFF
Date   Source Headline
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20208:37 amRNSIssue of Equity
2nd Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
21st Feb 202011:51 amRNSForm 8.3 - Redde PLC
21st Feb 20209:59 amRNSIssue of Equity
20th Feb 20201:54 pmRNSForm 8.3 - Redde PLC
18th Feb 202011:14 amRNSForm 8.3 - Redde PLC
18th Feb 202010:28 amRNSChange of Auditor
17th Feb 20202:44 pmRNSForm 8.3 - Redde PLC
13th Feb 20202:37 pmRNSIssue of Equity
13th Feb 20207:00 amRNSTeam Acquisition
7th Feb 20201:09 pmRNSForm 8.3 - Redde PLC
6th Feb 20202:45 pmRNSForm 8.3 - Redde PLC
5th Feb 20202:33 pmRNSForm 8.3 - Redde PLC
3rd Feb 202011:14 amRNSBlock listing Interim Review
28th Jan 20201:06 pmRNSForm 8.3 - Redde PLC
22nd Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
21st Jan 20202:26 pmRNSForm 8.3 - Redde PLC
21st Jan 20202:12 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20202:01 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20201:37 pmRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
16th Jan 202012:28 pmRNSForm 8.3 - Redde PLC
16th Jan 202012:26 pmRNSForm 8.3 - Consort Medical PLC
15th Jan 202012:20 pmRNSForm 8.3 - Redde PLC
14th Jan 202012:00 pmRNSForm 8.3 - Redde PLC
13th Jan 20201:49 pmRNSForm 8.3 - Redde Plc
10th Jan 20201:09 pmRNSForm 8.3 - Redde Plc
9th Jan 20207:00 amRNSAuM Update
30th Dec 201912:35 pmRNSForm 8.3 - Redde PLC
24th Dec 201911:35 amRNSForm 8.3 - Redde PLC
23rd Dec 20193:24 pmRNSForm 8.3 - Redde PLC
20th Dec 201911:18 amRNSForm 8.3 - Redde PLC
19th Dec 20192:17 pmRNSForm 8.3 - Redde PLC
18th Dec 20191:42 pmRNSForm 8.3 - Consort Medical PLC
17th Dec 201910:58 amRNSForm 8.3 - Consort Medical Plc
17th Dec 20199:37 amRNSHolding(s) in Company
6th Dec 20191:09 pmRNSForm 8.3 - Consort Medical Plc
5th Dec 20192:24 pmRNSForm 8.3 - Consort Medical Plc
4th Dec 20191:22 pmRNSForm 8.3 - Consort Medical Plc
2nd Dec 20191:59 pmRNSForm 8.3 - Redde PLC
2nd Dec 20197:00 amRNSTotal Voting Rights
25th Nov 20197:00 amRNSUnaudited interim results
20th Nov 20194:40 pmRNSSecond Price Monitoring Extn
20th Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20191:52 pmRNSBlock Listing Application
20th Nov 20191:30 pmRNSCrystallisation of Business Unit & Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.